by Richard Daverman, PhD
March 13, 2013 -- Shanghai Pharmaceuticals paid 444 million RMB ($72 million) to purchase an additional 20% stake in Chiatai Qingchunbao Pharmaceutical Co., a Hangzhou maker of TCM preparations and western chemical drugs. The 20% equity increases Shanghai Pharma’s holdings from 55% to 75%. More details....
Stock Symbols: (SHA: 601607; HK: 02607)
